Vitamin and Asthma Study

Phase 4

Completed

• Conditions: Asthma
• Interventions: Drug: Vitamin D

• Registration Number: NCT01447173
• Lead Sponsor: Augusta University

Brief Summary

The study looks at how vitamin D supplement will improve the severity of asthma and lung function as well as biomarkers in asthmatic children.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-12
• Primary Completion: 2011-09
• Study Completion: 2011-09
• Study First Submitted: 2011-10-03
• Study First Submitted QC: 2011-10-04
• Study First Posted: 2011-10-06
• Status Verified: 2012-10
• Last Update Submitted: 2012-10-22
• Last Update Posted: 2012-10-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• History of asthma (under control)otherwise in good general health

Exclusion Criteria

• Poorly controlled asthma
• Taking daily multivitamin or vitamin D supplementation
• Taking oral steroid medication
• History of bronchopulmonary dysplasia or chronic lung disease, extreme prematurity, congenital heart disease, significant renal dysfunction or primary kidney disease, endocrinologic abnormalities of calcium metabolism or parathyroid disorders

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
400 IU Vitamin D pill	Vitamin D	-
2000 IU vitamin D Daily	Vitamin D	-

Primary Outcome Measures

Name	Time	Method
Change in Pulmonary Function Test (PFT) after vitamin D supplementation	4 weeks
Change in Asthma Control Test (ACT) scores after vitamin D supplementation	4-week

Trial Locations

Locations (1)

Pediatrics Allergy Clinic at Georgia Health Sciences University; 🇺🇸 Augusta, Georgia, United States